Immix Biopharma, Inc.
IMMX
Revenue
20.00M
▲20.00M∞%
-Assets
20.08M
▲4.45M▲28.43%
3 Months ChangeLiabilities
11.82M
▲833.56k▲7.59%
3 Months ChangeFree Cash Flow
-1.75M
▲2.38M▲57.55%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-12
Form 10-Q
ID: 0001493152-24-031358
2024-07-26
Form 8-K
ID: 0001493152-24-029174
2024-07-22
Form 8-K
ID: 0001493152-24-028595
2024-06-14
Form 8-K
ID: 0001493152-24-023947
2024-05-20
Form 8-K
ID: 0001493152-24-020785
2024-05-09
Form 10-Q
ID: 0001493152-24-018458
2024-02-06
Form 8-K
ID: 0001493152-24-005043
2024-02-05
Form 8-K
ID: 0001493152-24-004933
2023-11-13
Form 10-Q
ID: 0001493152-23-040182
2023-08-22
Form 8-K
ID: 0001493152-23-029822